| Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL MA Nix, K Mandal, H Geng, N Paranjape, YHT Lin, JM Rivera, ... Cancer discovery 11 (8), 2032-2049, 2021 | 54 | 2021 |
| Defective Wnt3 expression by testicular Sertoli cells compromise male fertility S Basu, SP Arya, A Usmani, BS Pradhan, RK Sarkar, N Ganguli, M Shukla, ... Cell and tissue research 371, 351-363, 2018 | 29 | 2018 |
| Follicle-stimulating hormone-mediated decline in miR-92a-3p expression in pubertal mice Sertoli cells is crucial for germ cell differentiation and fertility A Gupta, A Vats, A Ghosal, K Mandal, R Sarkar, I Bhattacharya, S Das, ... Cellular and Molecular Life Sciences 79 (3), 136, 2022 | 21 | 2022 |
| Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma ID Ferguson, YHT Lin, C Lam, H Shao, KM Tharp, M Hale, C Kasap, ... Cell chemical biology 29 (8), 1288-1302. e7, 2022 | 18 | 2022 |
| An integrated transcriptomics-guided genome-wide promoter analysis and next-generation proteomics approach to mine factor (s) regulating cellular differentiation K Mandal, SL Bader, P Kumar, D Malakar, DS Campbell, BS Pradhan, ... Dna Research 24 (2), 143-157, 2017 | 16 | 2017 |
| Sertoli cell specific knockdown of RAR-related orphan receptor (ROR) alpha at puberty reduces sperm count in rats K Mandal, RK Sarkar, SS Sharma, A Jain, SS Majumdar Gene 641, 18-24, 2018 | 15 | 2018 |
| Declining levels of miR-382-3p at puberty trigger the onset of spermatogenesis A Gupta, K Mandal, P Singh, R Sarkar, SS Majumdar Molecular Therapy-Nucleic Acids 26, 192-207, 2021 | 13 | 2021 |
| Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target K Mandal, G Wicaksono, C Yu, JJ Adams, MR Hoopmann, WC Temple, ... Nature Cancer 4 (11), 1592-1609, 2023 | 12 | 2023 |
| Homeobox transcription factor Meis1 is crucial to Sertoli cell mediated regulation of male fertility RK Sarkar, S Sen Sharma, K Mandal, N Wadhwa, N Kunj, A Gupta, R Pal, ... Andrology 9 (2), 689-699, 2021 | 10 | 2021 |
| Loss of mitochondrial localization of human FANCG causes defective FANCJ helicase BS Kapoor, K Mandal, S Ghosh, RB Mokhamatam, SK Manna, ... Molecular and Cellular Biology, 2020 | 5 | 2020 |
| Structural surfaceomics reveals an AML-specific conformation of integrin-β2 as an immunotherapeutic target K Mandal, G Wicaksono, C Yu, JJ Adams, MR Hoopmann, WC Temple, ... Blood 140 (Supplement 1), 867-868, 2022 | 3 | 2022 |
| Structural surfaceomics reveals an AML-specific conformation of Integrin-β2 as a CAR-T therapy target K Mandal, G Wicaksono, C Yu, JJ Adams, MR Hoopmann, WC Temple, ... bioRxiv, 2022.10. 10.511511, 2022 | 1 | 2022 |
| AlphaCross-XL: a seamless tool for automated and proteome-scale map-ping of crosslinked peptides onto three-dimensional protein structures SV Shenoy, D Biswas, K Mandal, A Zalevsky, A Kishishita, A Verma, ... bioRxiv, 2025.01. 21.633663, 2025 | | 2025 |
| Development of Theranostic for Acute Myeloid Leukemia (AML) targeting activated conformation of integrin ï¢ 2 A Wadhwa, K Bobba, K Mandal, A Bidkar, A Raveendran, H Johnson, ... Journal of Nuclear Medicine 65 (supplement 2), 241872-241872, 2024 | | 2024 |
| P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA J Huebner, S Xirenayi, J Rivera, BP Escobar, AG Lee, K Mandal, ... HemaSphere 7 (S3), e40333db, 2023 | | 2023 |